APA (7th ed.) Citation

Zhou, J., Ji, Q., & Li, Q. (2021). Resistance to anti-EGFR therapies in metastatic colorectal cancer: Underlying mechanisms and reversal strategies. Journal of experimental & clinical cancer research, 40(1), 328-17. https://doi.org/10.1186/s13046-021-02130-2

Chicago Style (17th ed.) Citation

Zhou, Jing, Qing Ji, and Qi Li. "Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer: Underlying Mechanisms and Reversal Strategies." Journal of Experimental & Clinical Cancer Research 40, no. 1 (2021): 328-17. https://doi.org/10.1186/s13046-021-02130-2.

MLA (9th ed.) Citation

Zhou, Jing, et al. "Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer: Underlying Mechanisms and Reversal Strategies." Journal of Experimental & Clinical Cancer Research, vol. 40, no. 1, 2021, pp. 328-17, https://doi.org/10.1186/s13046-021-02130-2.